Enhancing Equity in Smoke-free Housing
Launched by HARVARD SCHOOL OF PUBLIC HEALTH (HSPH) · Sep 13, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study aims are:
Aim 1): Identify adaptations for a smokefree housing implementation framework and identify opportunities to integrate these adaptations with ongoing behavioral health support, to meet the needs of residents living in Permanent Supportive Housing (PSH) (Phase 1).
Aim 2): The research team will pilot test the adapted implementation framework, including an implementation toolkit, to assess the acceptability, feasibility and effectiveness of the primary intervention provided to Property Managers (Phase 2).
Aim 3): Based on a synthesis of qualitative and quantitative evide...
Gender
ALL
Eligibility criteria
- • The study setting is 6 affordable housing communities that include Permanent Supportive Housing (PSH) in Massachusetts, Maryland and New York (USA).
- Inclusion Criteria:
- • Adult residents of the six affordable housing communities who smoke or do not smoke tobacco, who receive or do not receive Permanent Supportive Housing services, and can complete a survey in English or Spanish.
- • Adult residents of the six affordable housing communities who smoke or do not smoke tobacco, who receive or do not receive Permanent Supportive Housing services, and can participate in a focus group discussion in English.
- • Property Managers (or their designated appointees) of the six affordable housing communities where the research will be conducted and able to receive the intervention and participate in the qualitative interviews in English.
- • Caseworkers who are dedicated health workers who provide behavioral health support (mental health and substance use support interventions) to residents at each of the six properties and who can receive the intervention and participate in the qualitative interviews in English.
- Exclusion Criteria:
- • Those unable to speak English or Spanish.
About Harvard School Of Public Health (Hsph)
The Harvard School of Public Health (HSPH), now part of Harvard T.H. Chan School of Public Health, is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and innovative research initiatives, HSPH focuses on addressing pressing global health challenges through multidisciplinary approaches. The institution actively sponsors clinical trials aimed at improving health outcomes, informing public policy, and enhancing community well-being. With a commitment to scientific excellence and social responsibility, HSPH collaborates with various stakeholders to translate research findings into practical solutions that benefit populations worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Vaughan Rees, PhD
Principal Investigator
Harvard University School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported